{"id":591787,"date":"2019-12-17T04:44:43","date_gmt":"2019-12-17T04:44:43","guid":{"rendered":"https:\/\/enterpriseam.com\/egypt\/2019\/12\/17\/gafi-intervenes-in-october-pharma-shareholder-dispute\/"},"modified":"2019-12-17T04:44:43","modified_gmt":"2019-12-17T04:44:43","slug":"gafi-intervenes-in-october-pharma-shareholder-dispute","status":"publish","type":"post","link":"https:\/\/enterpriseam.com\/egypt\/2019\/12\/17\/gafi-intervenes-in-october-pharma-shareholder-dispute\/","title":{"rendered":"GAFI intervenes in October Pharma shareholder dispute"},"content":{"rendered":"

DISPUTE WATCH- GAFI intervenes in OctoberPharma <\/strong>shareholder dispute: <\/strong>The General Authority for Freezones and Investment (GAFI) has prohibited HoldiPharma Chairman Ahmed Hegazy from serving on the board of OctoberPharma due to a potential conflict of interest, according to a GAFI letter obtained by Al Mal<\/a>. Acdima, which owns a 30% stake in October, had nominated Hegazy to represent the company on the board. The move was met with opposition from Emirati, Saudi, and Egyptian investors, who collectively own a 55% stake in the company, and called on the government to intervene. Concerns were raised that Hegazy\u2019s position at HoldiPharma might constitute a conflict of interest with his potential appointment in October. GAFI has invited Acdima to nominate a new representative to the board.<\/p>\n","protected":false},"excerpt":{"rendered":"

DISPUTE WATCH- GAFI intervenes in OctoberPharma shareholder dispute: The General Authority for Freezones and Investment (GAFI) has prohibited HoldiPharma Chairman Ahmed Hegazy from serving on the board of OctoberPharma due to a potential conflict of interest, according to a GAFI letter obtained by Al Mal. Acdima, which owns a 30% stake in October, had nominated […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"single-feature.php","format":"standard","meta":{"_acf_changed":false,"newspack_ads_suppress_ads":false,"newspack_popups_has_disabled_popups":false,"newspack_sponsor_sponsorship_scope":"","newspack_sponsor_native_byline_display":"inherit","newspack_sponsor_native_category_display":"inherit","newspack_sponsor_underwriter_style":"inherit","newspack_sponsor_underwriter_placement":"inherit","ep_exclude_from_search":false,"_primary_brand":0,"newspack_featured_image_position":"","newspack_post_subtitle":"","newspack_article_summary_title":"Overview:","newspack_article_summary":"","newspack_hide_updated_date":false,"newspack_show_updated_date":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[8572],"tags":[72,461,1320,10962,2380],"brand":[],"newspack_spnsrs_tax":[],"class_list":["post-591787","post","type-post","status-publish","format-standard","hentry","category-speed-round","tag-enterpriseam","tag-gafi","tag-holdipharma","tag-october-pharma","tag-speed-round","wpautop","entry"],"acf":{"mongo_id":"72afd5ca-739f-4e0c-be05-d26639191a76","is_powered_by":true,"section_story_id":"b4a3d9c2-a3fc-4c89-8f7c-72befbd95171","story_type":"1","photo_url":"","photo_position":"above","related_issue":[591774],"teaser":"","voice_url":""},"yoast_head":"\nGAFI intervenes in October Pharma shareholder dispute - EnterpriseAM Egypt<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/enterpriseam.com\/egypt\/2019\/12\/17\/gafi-intervenes-in-october-pharma-shareholder-dispute\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GAFI intervenes in October Pharma shareholder dispute\" \/>\n<meta property=\"og:description\" content=\"DISPUTE WATCH- GAFI intervenes in OctoberPharma shareholder dispute: The General Authority for Freezones and Investment (GAFI) has prohibited HoldiPharma Chairman Ahmed Hegazy from serving on the board of OctoberPharma due to a potential conflict of interest, according to a GAFI letter obtained by Al Mal. Acdima, which owns a 30% stake in October, had nominated […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/enterpriseam.com\/egypt\/2019\/12\/17\/gafi-intervenes-in-october-pharma-shareholder-dispute\/\" \/>\n<meta property=\"og:site_name\" content=\"EnterpriseAM Egypt\" \/>\n<meta property=\"article:published_time\" content=\"2019-12-17T04:44:43+00:00\" \/>\n<meta name=\"author\" content=\"enterpriseam admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"enterpriseam admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/12\/17\/gafi-intervenes-in-october-pharma-shareholder-dispute\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/12\/17\/gafi-intervenes-in-october-pharma-shareholder-dispute\/\"},\"author\":{\"name\":\"enterpriseam admin\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\"},\"headline\":\"GAFI intervenes in October Pharma shareholder dispute\",\"datePublished\":\"2019-12-17T04:44:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/12\/17\/gafi-intervenes-in-october-pharma-shareholder-dispute\/\"},\"wordCount\":129,\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"keywords\":[\"EnterpriseAM\",\"GAFI\",\"HoldiPharma\",\"October Pharma\",\"SPEED ROUND\"],\"articleSection\":[\"Speed Round\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/12\/17\/gafi-intervenes-in-october-pharma-shareholder-dispute\/\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/2019\/12\/17\/gafi-intervenes-in-october-pharma-shareholder-dispute\/\",\"name\":\"GAFI intervenes in October Pharma shareholder dispute - EnterpriseAM Egypt\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\"},\"datePublished\":\"2019-12-17T04:44:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/12\/17\/gafi-intervenes-in-october-pharma-shareholder-dispute\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/enterpriseam.com\/egypt\/2019\/12\/17\/gafi-intervenes-in-october-pharma-shareholder-dispute\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/12\/17\/gafi-intervenes-in-october-pharma-shareholder-dispute\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/enterpriseam.com\/egypt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GAFI intervenes in October Pharma shareholder dispute\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"name\":\"EnterpriseAM\",\"description\":\"The State of the Nation\",\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\",\"name\":\"EnterpriseAM\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ent.news\/internal\/240894.svg\",\"contentUrl\":\"https:\/\/ent.news\/internal\/240894.svg\",\"caption\":\"EnterpriseAM\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\",\"name\":\"enterpriseam admin\",\"sameAs\":[\"http:\/\/enterpriseam.testing.projectsarea.com\"],\"url\":\"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"GAFI intervenes in October Pharma shareholder dispute - EnterpriseAM Egypt","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/enterpriseam.com\/egypt\/2019\/12\/17\/gafi-intervenes-in-october-pharma-shareholder-dispute\/","og_locale":"en_US","og_type":"article","og_title":"GAFI intervenes in October Pharma shareholder dispute","og_description":"DISPUTE WATCH- GAFI intervenes in OctoberPharma shareholder dispute: The General Authority for Freezones and Investment (GAFI) has prohibited HoldiPharma Chairman Ahmed Hegazy from serving on the board of OctoberPharma due to a potential conflict of interest, according to a GAFI letter obtained by Al Mal. Acdima, which owns a 30% stake in October, had nominated […]","og_url":"https:\/\/enterpriseam.com\/egypt\/2019\/12\/17\/gafi-intervenes-in-october-pharma-shareholder-dispute\/","og_site_name":"EnterpriseAM Egypt","article_published_time":"2019-12-17T04:44:43+00:00","author":"enterpriseam admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"enterpriseam admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/enterpriseam.com\/egypt\/2019\/12\/17\/gafi-intervenes-in-october-pharma-shareholder-dispute\/#article","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/2019\/12\/17\/gafi-intervenes-in-october-pharma-shareholder-dispute\/"},"author":{"name":"enterpriseam admin","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d"},"headline":"GAFI intervenes in October Pharma shareholder dispute","datePublished":"2019-12-17T04:44:43+00:00","mainEntityOfPage":{"@id":"https:\/\/enterpriseam.com\/egypt\/2019\/12\/17\/gafi-intervenes-in-october-pharma-shareholder-dispute\/"},"wordCount":129,"publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"keywords":["EnterpriseAM","GAFI","HoldiPharma","October Pharma","SPEED ROUND"],"articleSection":["Speed Round"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/enterpriseam.com\/egypt\/2019\/12\/17\/gafi-intervenes-in-october-pharma-shareholder-dispute\/","url":"https:\/\/enterpriseam.com\/egypt\/2019\/12\/17\/gafi-intervenes-in-october-pharma-shareholder-dispute\/","name":"GAFI intervenes in October Pharma shareholder dispute - EnterpriseAM Egypt","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/#website"},"datePublished":"2019-12-17T04:44:43+00:00","breadcrumb":{"@id":"https:\/\/enterpriseam.com\/egypt\/2019\/12\/17\/gafi-intervenes-in-october-pharma-shareholder-dispute\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/enterpriseam.com\/egypt\/2019\/12\/17\/gafi-intervenes-in-october-pharma-shareholder-dispute\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/enterpriseam.com\/egypt\/2019\/12\/17\/gafi-intervenes-in-october-pharma-shareholder-dispute\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/enterpriseam.com\/egypt\/"},{"@type":"ListItem","position":2,"name":"GAFI intervenes in October Pharma shareholder dispute"}]},{"@type":"WebSite","@id":"https:\/\/enterpriseam.com\/egypt\/#website","url":"https:\/\/enterpriseam.com\/egypt\/","name":"EnterpriseAM","description":"The State of the Nation","publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/enterpriseam.com\/egypt\/#organization","name":"EnterpriseAM","url":"https:\/\/enterpriseam.com\/egypt\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/","url":"https:\/\/ent.news\/internal\/240894.svg","contentUrl":"https:\/\/ent.news\/internal\/240894.svg","caption":"EnterpriseAM"},"image":{"@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d","name":"enterpriseam admin","sameAs":["http:\/\/enterpriseam.testing.projectsarea.com"],"url":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"}]}},"featured_image_src":null,"featured_image_src_square":null,"author_info":{"display_name":"enterpriseam admin","author_link":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":568681,"url":"https:\/\/enterpriseam.com\/egypt\/2020\/01\/30\/acdima-pharma-chairman-steps-down-citing-differences-with-shareholders\/","url_meta":{"origin":591787,"position":0},"title":"ACDIMA Pharma Chairman steps down citing differences with shareholders","author":"enterpriseam admin","date":"30 January 2020","format":false,"excerpt":"MOVES- Chairman Ahmed Hegazy has resigned from his position as chairman of October Pharma, sources close to the company told Al Mal. Hegazy is also the chairman of ACDIMA Pharma, which owns a 30% stake in October. ACDIMA shareholders reportedly raised conflict of interest concerns arising from Hegazy simultaneously holding\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":560904,"url":"https:\/\/enterpriseam.com\/egypt\/2021\/03\/17\/ashraf-el-kholy-appointed-ceo-of-holdipharma\/","url_meta":{"origin":591787,"position":1},"title":"Ashraf El Kholy appointed CEO of HoldiPharma","author":"enterpriseam admin","date":"17 March 2021","format":false,"excerpt":"Ashraf El Kholy (LinkedIn) has been appointed as the CEO of state-owned HoldiPharma, Youm7 reports. El Kholy served as the vice president and corporate affairs and communication director at Pfizer Egypt between 2013 and 2019, and Bayer\u2019s Egypt manager during 2007-2013. The company has also appointed Ahmed Hegazy as chairman\u2026","rel":"","context":"In "Moves"","block_context":{"text":"Moves","link":"https:\/\/enterpriseam.com\/egypt\/category\/newsmakers\/moves\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":591782,"url":"https:\/\/enterpriseam.com\/egypt\/2019\/12\/17\/baker-mckenzie-explains-egypts-latest-investment-act-exec-reg-amendments-on-foreign-investment-data\/","url_meta":{"origin":591787,"position":2},"title":"Baker McKenzie explains Egypt\u2019s latest Investment Act exec reg amendments on foreign investment data","author":"enterpriseam admin","date":"17 December 2019","format":false,"excerpt":"If your company has a foreign investor in its shareholder base, GAFI wants extra data from you every quarter: The Investment Ministry issued last month amendments to the Investment Act that will require public and private entities alike to submit quarterly report to the General Authority for Freezones and Investment\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":638726,"url":"https:\/\/enterpriseam.com\/egypt\/2017\/10\/12\/gafi-approves-three-investment-zones\/","url_meta":{"origin":591787,"position":3},"title":"GAFI approves three investment zones","author":"enterpriseam admin","date":"12 October 2017","format":false,"excerpt":"The General Authority for Freezones and Investments (GAFI) approved the establishment of three new investment zones yesterday, according to an Investment Ministry statement. Those include an SME-focused zone in Qalyubia and two commercial zones for the Majid Al Futtaim Group at the Six October City Mall of Egypt and the\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":584302,"url":"https:\/\/enterpriseam.com\/egypt\/2023\/03\/29\/holdipharma-to-partner-with-private-sector-on-5-new-factories\/","url_meta":{"origin":591787,"position":4},"title":"HoldiPharma to partner with private sector on 5 new factories","author":"enterpriseam admin","date":"29 March 2023","format":false,"excerpt":"State-owned HoldiPharma wants to reduce reliance on imports","rel":"","context":"In "Manufacturing"","block_context":{"text":"Manufacturing","link":"https:\/\/enterpriseam.com\/egypt\/category\/industries\/manufacturing\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2023\/3\/576.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":588455,"url":"https:\/\/enterpriseam.com\/egypt\/2023\/06\/12\/negotiations-are-underway-for-investments-in-two-state-owned-pharma-firms-through-a-capital-increase\/","url_meta":{"origin":591787,"position":5},"title":"Negotiations are underway for investments in two state-owned pharma firms through a capital increase","author":"enterpriseam admin","date":"12 June 2023","format":false,"excerpt":"CID could soon have more than one shareholder","rel":"","context":"In "Privatization"","block_context":{"text":"Privatization","link":"https:\/\/enterpriseam.com\/egypt\/category\/business\/privatization-watch\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2023\/6\/531.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]}],"_links":{"self":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/591787","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/comments?post=591787"}],"version-history":[{"count":0,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/591787\/revisions"}],"acf:post":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/issue\/591774"}],"wp:attachment":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/media?parent=591787"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/categories?post=591787"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/tags?post=591787"},{"taxonomy":"brand","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/brand?post=591787"},{"taxonomy":"newspack_spnsrs_tax","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/newspack_spnsrs_tax?post=591787"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}